149 related articles for article (PubMed ID: 20658994)
1. NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease.
Landrieu I; Leroy A; Smet-Nocca C; Huvent I; Amniai L; Hamdane M; Sibille N; Buée L; Wieruszeski JM; Lippens G
Biochem Soc Trans; 2010 Aug; 38(4):1006-11. PubMed ID: 20658994
[TBL] [Abstract][Full Text] [Related]
2. NMR analysis of a Tau phosphorylation pattern.
Landrieu I; Lacosse L; Leroy A; Wieruszeski JM; Trivelli X; Sillen A; Sibille N; Schwalbe H; Saxena K; Langer T; Lippens G
J Am Chem Soc; 2006 Mar; 128(11):3575-83. PubMed ID: 16536530
[TBL] [Abstract][Full Text] [Related]
3. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
4. High-resolution magic angle spinning NMR of the neuronal tau protein integrated in Alzheimer's-like paired helical fragments.
Sillen A; Wieruszeski JM; Leroy A; Younes AB; Landrieu I; Lippens G
J Am Chem Soc; 2005 Jul; 127(29):10138-9. PubMed ID: 16028903
[TBL] [Abstract][Full Text] [Related]
5. Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules.
Fischer D; Mukrasch MD; Biernat J; Bibow S; Blackledge M; Griesinger C; Mandelkow E; Zweckstetter M
Biochemistry; 2009 Oct; 48(42):10047-55. PubMed ID: 19769346
[TBL] [Abstract][Full Text] [Related]
6. NMR investigation of the interaction between the neuronal protein tau and the microtubules.
Sillen A; Barbier P; Landrieu I; Lefebvre S; Wieruszeski JM; Leroy A; Peyrot V; Lippens G
Biochemistry; 2007 Mar; 46(11):3055-64. PubMed ID: 17311412
[TBL] [Abstract][Full Text] [Related]
7. Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy.
Sibille N; Sillen A; Leroy A; Wieruszeski JM; Mulloy B; Landrieu I; Lippens G
Biochemistry; 2006 Oct; 45(41):12560-72. PubMed ID: 17029411
[TBL] [Abstract][Full Text] [Related]
8. Tau phosphorylation in neuronal cell function and dysfunction.
Johnson GV; Stoothoff WH
J Cell Sci; 2004 Nov; 117(Pt 24):5721-9. PubMed ID: 15537830
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and conformational properties of phosphopeptides related to the human tau protein.
Du JT; Li YM; Ma QF; Qiang W; Zhao YF; Abe H; Kanazawa K; Qin XR; Aoyagi R; Ishizuka Y; Nemoto T; Nakanishi H
Regul Pept; 2005 Aug; 130(1-2):48-56. PubMed ID: 15869817
[TBL] [Abstract][Full Text] [Related]
10. Application of synthetic phospho- and unphospho- peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's disease.
Liu WK; Moore WT; Williams RT; Hall FL; Yen SH
J Neurosci Res; 1993 Feb; 34(3):371-6. PubMed ID: 8455212
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation modulates the local conformation and self-aggregation ability of a peptide from the fourth tau microtubule-binding repeat.
Du JT; Yu CH; Zhou LX; Wu WH; Lei P; Li Y; Zhao YF; Nakanishi H; Li YM
FEBS J; 2007 Oct; 274(19):5012-20. PubMed ID: 17725643
[TBL] [Abstract][Full Text] [Related]
12. Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS.
Ma Q; Li Y; Du J; Liu H; Kanazawa K; Nemoto T; Nakanishi H; Zhao Y
Peptides; 2006 Apr; 27(4):841-9. PubMed ID: 16225961
[TBL] [Abstract][Full Text] [Related]
13. The self-assembly ability of the first microtubule-binding repeat from tau and its modulation by phosphorylation.
Zhou LX; Zeng ZY; Du JT; Zhao YF; Li YM
Biochem Biophys Res Commun; 2006 Sep; 348(2):637-42. PubMed ID: 16889747
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Alzheimer's-like paired helical filaments from the core domain of tau protein using solid-state NMR spectroscopy.
Andronesi OC; von Bergen M; Biernat J; Seidel K; Griesinger C; Mandelkow E; Baldus M
J Am Chem Soc; 2008 May; 130(18):5922-8. PubMed ID: 18386894
[TBL] [Abstract][Full Text] [Related]
15. The Study of Posttranslational Modifications of Tau Protein by Nuclear Magnetic Resonance Spectroscopy: Phosphorylation of Tau Protein by ERK2 Recombinant Kinase and Rat Brain Extract, and Acetylation by Recombinant Creb-Binding Protein.
Qi H; Despres C; Prabakaran S; Cantrelle FX; Chambraud B; Gunawardena J; Lippens G; Smet-Nocca C; Landrieu I
Methods Mol Biol; 2017; 1523():179-213. PubMed ID: 27975251
[TBL] [Abstract][Full Text] [Related]
16. p44mpk MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons.
Lu Q; Soria JP; Wood JG
J Neurosci Res; 1993 Jul; 35(4):439-44. PubMed ID: 7689658
[TBL] [Abstract][Full Text] [Related]
17. Neighbored phosphorylation sites as PHF-tau specific markers in Alzheimer's disease.
Singer D; Lehmann J; Hanisch K; Härtig W; Hoffmann R
Biochem Biophys Res Commun; 2006 Aug; 346(3):819-28. PubMed ID: 16781671
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization by nuclear magnetic resonance of the impact of phosphorylation in the proline-rich region of the disordered Tau protein.
Sibille N; Huvent I; Fauquant C; Verdegem D; Amniai L; Leroy A; Wieruszeski JM; Lippens G; Landrieu I
Proteins; 2012 Feb; 80(2):454-62. PubMed ID: 22072628
[TBL] [Abstract][Full Text] [Related]
19. Modification of tau to an Alzheimer's type protein interferes with its interaction with microtubules.
González C; Farías G; Maccioni RB
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1117-27. PubMed ID: 9846894
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules.
Amniai L; Barbier P; Sillen A; Wieruszeski JM; Peyrot V; Lippens G; Landrieu I
FASEB J; 2009 Apr; 23(4):1146-52. PubMed ID: 19074508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
